David Rosen, a partner and member of the Life Sciences and Nanotechnology Industry Teams, will be moderating a panel for the Tech Council of Maryland entitled, “Nanomedicine, Opportunities and Challenges.” The session will be taking place at John Hopkins University on September 12, 2007.
The panel will discuss the promises as well as some of the challenges are to creating these new therapies that may be safer and more effective in treating life-threatening diseases.
Panelists include:
- Dr. Hamid Ghandehari, Director, University of Maryland School of Pharmacy, Center for Nanomedicine and Cellular Delivery, Department of Pharmaceutical Sciences
- Dr. Chiming Wei, Department of Surgery, The Johns Hopkins School of Medicine and President, American Academy of Nanomedicine
- Dr. Lawrence Tamarkin, President & CEO, CytImmune Sciences, Inc.
People
Related Insights
December 24, 2025
Health Care Law Today
Gender-Affirming Care: Multi‑State Lawsuit Challenges HHS Declaration
As previously discussed in Foley’s healthcarelawtoday, on December 18, 2025, the U.S. Department of Health & Human Services (HHS) held a press conference focused on what it defined as “sex rejection procedures” (SRPs), also known as gender-affirming care (GAC) for minors, and outlined next steps.
December 23, 2025
Energy Current
FERC Opens New Paths for Co-Located Loads in PJM: What Data Center and Power Generation Developers Need to Know
Key Takeaways FERC has ordered PJM to overhaul its tariff framework for co-located generation and large loads, finding existing rules…
December 23, 2025
Foley Viewpoints
The Rush to Exit: PE Firms Pick Up the Pace in 2025
Key Points: PE firms are moving to sell portfolio companies on an accelerated timeline in 2025 after years of much longer hold…